Advertisement
Canada markets close in 4 hours 24 minutes
  • S&P/TSX

    22,369.22
    -6.61 (-0.03%)
     
  • S&P 500

    5,216.34
    +2.26 (+0.04%)
     
  • DOW

    39,444.74
    +56.98 (+0.14%)
     
  • CAD/USD

    0.7319
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    79.14
    -0.12 (-0.15%)
     
  • Bitcoin CAD

    83,614.52
    -1,151.73 (-1.36%)
     
  • CMC Crypto 200

    1,264.60
    -93.41 (-6.88%)
     
  • GOLD FUTURES

    2,370.30
    +30.00 (+1.28%)
     
  • RUSSELL 2000

    2,058.61
    -15.02 (-0.72%)
     
  • 10-Yr Bond

    4.5000
    +0.0510 (+1.15%)
     
  • NASDAQ

    16,324.00
    -22.26 (-0.14%)
     
  • VOLATILITY

    12.81
    +0.12 (+0.95%)
     
  • FTSE

    8,440.21
    +58.86 (+0.70%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6793
    +0.0015 (+0.22%)
     

Nektar Therapeutics: Positive Data from Phase 3 NKTR-181 Trial

Nektar Therapeutics' (NKTR) NKTR-181 has already received fast-track designation from the FDA (U.S. Food & Drug Administration).